U.S. Markets closed

Syneron Medical Ltd. (ELOS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.85-0.05 (-0.46%)
At close: 4:00PM EDT
People also watch
  • Thanks for the tip, I did some research and found more information about $ELOS on http://thesubwaytrader.com/?s=ELOS Investing making money. The basic law of construction: cut it large and kick it into place.

    The Subway Trader: Trading Stocks and Making Money
    Stock alerts from the The Subway Trader. Stock trading, making money and always looking for the next big money maker.
  • The last time ELOS did something like this it blew up. have you guys heard of awesome-STOCKS. i started receiving their allerts and so far i am happy.
  • I wonder if Stephen Fanning, from our BOD, has checked if his former employer, Johnson & Johnson, is interested in making a bid.

    It seems like a perfect fit.
  • What are the odds of someone showing up before May 9th to compete with Allergan?
  • At least we got:-
    "The merger agreement includes a "go-shop" period which ends on May 9, 2017. During this period, Syneron Candela, with the assistance of Barclays, will actively solicit, evaluate and potentially enter into negotiations with respect to alternative proposals from third parties. There can be no assurance that this process will result in receipt of a superior offer or that any other transactions may be approved or consummated. Syneron Candela does not intend to disclose developments about this process unless and until its board has made a decision with respect to any potential superior proposal."
  • What's happening here has been done many times.
    The company is put on the block. An ultra low offer is made, and, if nobody makes a bid, the ultra low offer succeeds.
    It's unfortunate that shareholders have no input into how the shopping of the company proceeds.
  • I think ELOS might have reached its upward limit and that a pullback may be possible. Not sure how awesome-STOCKS finds all these incredible trade ideas but im happy.
  • Is it time to make a move on ELOS? It certainly looks like it based on a P/E(ttm) of 115.12. google awesom-eSTOCKS - they offer pretty good trade alerrts. you dont have to trade their tickers but it definetly helps you recognize possible patterns for stocks you're trading.
  • What happened to Apax deal ??Fake news!
  • Can anyone explain how Syneron's market cap can be less than one sixth of ZLTQ's market cap?

    The businesses look very similar in size to me.
  • In my opinion, any reasonable takeover offer is good for shareholders. "Reasonable" means about 30% premium. It is absurd to expect 200% premium or something; it never happens.
  • I'd be willing to sell for half the multiples used in the Allergan purchase of our competitor, Zeltiq. Unlike Syneron, Zeltix is losing money hand over fist so half seems beyond fair to me.
    That would put Syneron acquisition price just above $30 per share and still give Apax a 50% market discount versus the Zeltiq deal.

    In any case, it seems to me offers anywhere near the current market cap should be regarded as absurd.
  • statement: my break even number is twenty two.probably i won'tlive long enough to see that. well,what can i say?the only thing i can do is try.good luck to all longs.
  • Found a great no fee daytrading newsletter, vist www.TopMarketGainers.com and sign up...so glad I did

    Top Market Gainers
  • You're confusing product with process. Most people, when they criticize, whether they like it or hate it, they're talking about product. That's not art, that's the result of art. Art, to whatever degree we can get a handle on (I'm not sure that we really can) is a process. It begins in the heart and the mind with the eyes and hands. http://dataunion.tistory.com/1803

    [2016-MAY] Syneron Medical Ltd. NASDAQ : ELOS Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is 0 In other words, the correlation coefficient of the other stocks
  • Atrocious mismanagement in the US last quarter is proving costly despite the best efforts of the scientists.
  • Once the market gets over its disappointment with the FDA approval, this should recover!